chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Resident did not receive 2nd dose of Moderna COVID-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Resident did not receive 2nd dose of Moderna COVID-19 vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Resident did not receive 2nd dose of Moderna COVID-19 vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Resident did not receive 2nd dose of Moderna COVID-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided. No treatment details were provided   Reporter did not allow further contact
She developed a case of shingles. Administered SHINGRIX on 5/1/18 and received medication for antiviral on 5/10/18. She was immunosuppressed and under supervision of oncology doctor.
Patient states she had a small rash around injection site on 12/8 which has went away. Now she is claiming since 12/13 she is itching underneath her skin up and down her arms.
Patient received vaccine on 08-Apr-2022/Vaccine expired on 07-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine on 08-Apr-2022/Vaccine expired on 07-Apr-2022) in a 56-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine on 08-Apr-2022/Vaccine expired on 07-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine on 08-Apr-2022/Vaccine expired on 07-Apr-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. Vaccine manufacture date of expiry reported was 07-Apr-2022. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up received contains no new information.
Information had been received on 06-JUL-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a male patient of unknown age was inoculated with ZOSTAVAX vaccine (dose, route, site of administration, lot # and expiration date were not provided) on or about 15-SEP-2011 at a medical group office facility, as recommended for routine adult health maintenance and for the prevention of shingles. The patient's medical history, concurrent conditions and concomitant medication were not provided. The lawyer reported, the ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of Herpes Zoster. On or about 20-JAN-2014, the patient broke out with a blistering vesicular rash accompanied by symptoms of weakened immunity. On or about 12-JAN-2015 the male was treated (Treatment not specified) by a physician at the medical group office facility (same place where he received vaccination on or about 15-SEP-2011) in which his condition was diagnosed as herpes zoster. As a direct and proximate result of these malfunctions, patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Information has been received from a registered nurse concerning a 23 year old female with Graves' disease, latex allergy and poppy seeds allergy who on 19-SEP-2008 was vaccinated with the first dose of GARDASIL and on 25-NOV-2008 received the second dose of GARDASIL. It was reported that 4 to 5 hours after the second dose the patient experienced arm pain and swollen, red, tingling hands. The reaction lasted for 1 hour and then resolved with no complications. The nurse stated that the patient will not receive the third dose of GARDASIL. Additional information has been requested.
A couple of hours after receiving the vaccine a co-worker said my eyes were very low and red. I started feeling extremely exhausted and even slept on my shift on my desk. My supervisor told me to go home for the day.  I went home and slept through the day and night until next morning. I then started feeling myself again.
Very large welt-like injection site reaction, no rash, started day after pt received vaccine. Minimal pain, but reaction had about 6-7" diameter, also bruised looking.
Scratchy sore throat, cough with wheezing on expiration, chest tightness, throat swelling, hoarseness.
Extreme fatigue. Nausea. Moderate pain and left shoulder. Temperature of 101
Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with ACYCLOVIR [ACICLOVIR] for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.    For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-239102, MOD-2021-239102.
Patient is 42 years old, gave the High Dose  FluAD. no Adverse effect, just incorrect product selection.
25 Jan evening-fatigue, sleepy, injection site red, HA, runny nose 26th Jan 2021-more fatigued, low back, hips, legs achy, runny nose, HA 27th January-SAME-nose stopped running, increased fatigue, site of injection-more red/swollen, rt armpit-achy & swollen Treatment-she said she took an aleve this AM-27th Jan, and she will get some PEDILYTE today to sip
COVID-19; severe hot flashes; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), HOT FLUSH (severe hot flashes), HEADACHE (headache) and FATIGUE (fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Aspirin, vancomycin incision powder), Asthma, Depression, Anxiety and Atrophic vaginitis. Concomitant products included FAMOTIDINE from 01-Jan-2020 to an unknown date for GERD.   On 13-Jan-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2. On 15-Jan-2021, the patient experienced HOT FLUSH (severe hot flashes), HEADACHE (headache) and FATIGUE (fatigue). On 21-Jan-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, HOT FLUSH (severe hot flashes), HEADACHE (headache) and FATIGUE (fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Jan-2021, Polymerase chain reaction: (Positive) PCR nasal swab test taken 1/19/21 and returned positive 1/21/21..         March 13 took first COVID vaccine, morning of 1/15/21 I awoke with runny nose, severe hot flashes, headache and fatigue. I reported symptoms to my meployer who requested testing. PCR nasal swab test taken 1/19/21 and returned positive 1/21/21. Headache and hot flashed were severe. Runny nose, marked fatigue and brain fogginess noted. In 5 days I lost taste and smell, increased fatigue, hot flashes and headache.  I used tylenol 500mg 2 tabs every 6 hours for headache, test and fluids as tolerated COVID infection in March 2020 was much more severe with lung symptoms, fever, gi problems. COVID infection in January 2021 much more mild but continue brain fog is annoying.
I saw hives starting at 10:15 pm.  I was able to sleep from 11:00-midnight, then was awake with increasing amount of hives. At 3:00 am, I contacted Ask-a-nurse who recommended I contact a physician or go to the ER. I had a Telehealth visit at 4:00 am, with an internal medicine MD. She suggested that usually hives are treated with a steroid, however since I had recently had the 2nd dose of COVID vaccine, it was not recommended as it would decrease my immune system further. She prescribed hydroxine HCL 25 mg. Monday morning I picked up some Benadryl, as the 24 hr pharmacy was not nearby. I took a nap then felt groggy the rest of the day. A pharmacist friend suggested I take Pepcid and Claritin (non-drowsy), then the hydroxine at night. I started this regime on Tuesday. Hives continued to come, then go on different areas of my body through Friday (5/7/21) around noon. I continued to take the above stated medications through Sat. to ensure the hives would not return. I have several pictures of the hives from various days if interested in them. Many of them were large and raised up about 1/8" (ie. One was the size of a racquetball in the bend in my elbow; another was about 3/4 distance across my waistline).
Intense pain that radiated through the muscle from the vaccine site.  Each vaccine has gotten progressively worse. More painful restricted movement and lasting longer even when taking over the counter pain meds. Did not feel relief  until  middle of the 4th day. Still feel a residue ache that seems to have settled into the adjoining area. Ended up taking 4-6 ibuprofen every 4 hours  when that wasn?t touching it I took 2 Tylenol in between.
Patient evaluated at local hospital for concern for meningitis / encephalitis, transferred to our facility and was able to get studies (detailed below some of which are still pending).   Initial symptoms presented with rhinorrhea, then severee headache, neck pain, and fever (tactile). Had sweats and chills. Began to experience diarrhea, dysuria, diffue body aches and myalgias. Severe pain in his neck / posterior occiput. Denied any mental status changes at the time.   Studies largely negative for an identifiable bacterial process so presumptive diagnosis is aseptic meningitis. Unclear if from vaccine or other etiologies. Outside hospital had started antibiotics but this was stopped and patient symptomatically recovered with only symptomatic care.
Hives to adjacent area. Treated with over the counter MOTRIN and BENADRYL.
18NOV96 pt recv vax in clinic;19NOV96 arm began swelling cont to swell & became painful-knot was there;25NOV96 MD visit-put on ATB arm extremely swollen from shoulder to elbow, red, hot;26NOV96 arm still swollen;
Severe pain in my right arm at and near the injection site. It hurts to move the arm - especially in certain positions such as reaching, pulling, pushing, putting behind my back. Physical Therapy 2x per week. Not due to vaccine, but to location of injection site.
a 6-inch lump on her whole top of her shoulder or biceps area; rash; itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), VACCINATION SITE MASS (a 6-inch lump on her whole top of her shoulder or biceps area) and RASH (rash) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PRURITUS (itchy). On 18-Feb-2021, the patient experienced VACCINATION SITE MASS (a 6-inch lump on her whole top of her shoulder or biceps area) and RASH (rash). At the time of the report, PRURITUS (itchy), VACCINATION SITE MASS (a 6-inch lump on her whole top of her shoulder or biceps area) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided
Immediate headache at the time of the shot on Sunday. Felt like I had covid again. By Wednesday I was dizzy and vomiting. Symptoms lasted 9 days and an extra 7 days of fatigue
12h after administration, patient developed dysphagia and dysarthria with RL facial droop. Diagnosed with acute ischemic CVA of left corona radiata.
On 1/20, I got a headache, dizziness, and my arm was extremely sore. Within about an hour, I became extremely nauseous and had both chills and sweats. I took my temperature at 6:00 pm on 1/20 and it read 99.7. I then took tylenol and at 8:30, I took my temperature again and it was 100.5. My normal temperature is 97.2-97.5. I took an ice bath at this point as my arm at the injection site was extremely swollen, hard, and hot to the touch. I called urgent care to see what medications I could take in addition to tylenol and they recommended motrin to bring down my fever. I woke up several times through the night and took medication. At around 8 am on 1/21, I took my temperature and it was 97.8.
In August 2021 first my knee wasn't bending normally and then I noted my left foot was swelling. My wrists and hands were also swelling. I have had muscle aches and stiff joints all over. I have also been having itchy spells in various places on my body. In 08/2021 my doctor gave me a dose of antihistamine and the itching stopped. My foot is still swollen, however. I saw my PCP and she did various blood tests, and everything came back normal. I went to see my Endocrinologist and was diagnosed with celiac disease on 10/10/2021. My foot is less swollen, but my hands and wrist are still swollen. I still have muscle aches and stiff joints as well.
On 01/24 the pt developed reddened, swollen left upper arm and was admitted to the hospital. More swelling developed the next day. Possible cellulitis from DTap reaction.
Soreness; The entire arm is hot touch; Hardness; Swelling; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), INJECTION SITE WARMTH (The entire arm is hot touch), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Soreness), INJECTION SITE WARMTH (The entire arm is hot touch), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness). At the time of the report, PAIN (Soreness), INJECTION SITE WARMTH (The entire arm is hot touch), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Redness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up was received. Outcome of all events were updated to recovered/resolved. Reporter declined further follow-up. It contains significant information.
high fever for two days, vomiting only once, diarrhea, dizziness, a lot of abdominal pain, headache
Approx 10" after vaccine c/o "tingling" sensation in throat. States has had anaphylaxis on several occasions and knew the feeling. Took 50 mg BENADRYL PO.
Doctor has deemed me disabled. Short term memory recall, ADHD,  fainting and falling, pre-fainting, testosterone depletion, unemployed and unable to get a job or financial assistance. Please help!!
1ST DOSE OF MODERNA 3/12/2021 2ND DOSE OF PFIZER 4/09/21
missed periods following each vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 10Apr2021 (Batch/Lot number: unknown) as dose 1, single and administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Concomitant medication(s) included: LEVOTHYROXINE; METFORMIN; TYLENOL; ADVIL [IBUPROFEN]. The following information was reported: MENSTRUAL DISORDER (non-serious) with onset 2021, outcome "unknown", described as "missed periods following each vaccine". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of menstrual disorder.  Additional information: Noted missed periods following each vaccine shot and booster. Occurred with after each shot in series as well. The patient received no other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19 prior to vaccination and has tested for COVID-19 since the vaccination.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt experienced tingling on right side of body around rib cage area, red marks on trunk. According to mother behavioral changes were present for 2 days. On 3/25/06 taken to ER because of marks on trunk. Doctor was not sure whether they were shingles because pt reported no pain, nevertheless pt prescribed Acyclovir and the use of calamine lotion to help lesions dry. On 4/2/06 Boil appeared on front lower right rib, taken to the doctor on 4/6/06 which mentioned that it was a staphylococcal infection related to shingles. Pt prescribed Bioxion XL for 5 days. Today mother reports that the lesions are healing and scabbing using Neosporin to help healing but pt reports no pain.
patient had itching of anterior forearms requiring diphenhydramine 25 mg orally for relief
had another stroke; blood clots in brain; Difficult to control right hand; difficult to speak; had a stroke and went to the hospital; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of CEREBROVASCULAR ACCIDENT (had another stroke), CEREBRAL THROMBOSIS (blood clots in brain), TRANSIENT ISCHAEMIC ATTACK (had a stroke and went to the hospital), DYSKINESIA (Difficult to control right hand) and DYSARTHRIA (difficult to speak) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 039A20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 12-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 21-Feb-2021, the patient experienced TRANSIENT ISCHAEMIC ATTACK (had a stroke and went to the hospital) (seriousness criterion medically significant).  On 23-Feb-2021, the patient experienced CEREBROVASCULAR ACCIDENT (had another stroke) (seriousness criteria hospitalization and medically significant), CEREBRAL THROMBOSIS (blood clots in brain) (seriousness criterion hospitalization), DYSKINESIA (Difficult to control right hand) (seriousness criterion hospitalization) and DYSARTHRIA (difficult to speak) (seriousness criterion hospitalization).   The patient was hospitalized from 23-Feb-2021 to 26-Feb-2021 due to CEREBRAL THROMBOSIS, CEREBROVASCULAR ACCIDENT, DYSARTHRIA and DYSKINESIA.   At the time of the report, CEREBROVASCULAR ACCIDENT (had another stroke), CEREBRAL THROMBOSIS (blood clots in brain), TRANSIENT ISCHAEMIC ATTACK (had a stroke and went to the hospital), DYSKINESIA (Difficult to control right hand) and DYSARTHRIA (difficult to speak) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication use was not reported.   Treatment for the events included Plavix.; Sender's Comments: Although a temporal association exist,  critical details such as the patient's medical history, list of concomitant medication are lacking .  Pending additional information, causality with mRNA-1273  administration cannot be confirmed for all events.
severe joint and muscle pain,  barely able to walk.   Subsided after 12 hours without treatment south residual,  bearable pain 72 hours post injection.
The doctor advised me to take Allegra and a before and the day of the 2nd vaccine. I went home afterwards and slept. Not sure if there were any reactions to this one.
Patient received immunizations on 7/15/04. By 7/17/04, patient's right arm was red, swollen, and had blisters from the elbow to the shoulder.  Nurse follow up on 08/31/04 states: "Cellulitis, inflammatory reaction, tender, tonsils erythema."
As technician was administering vaccine, at 0.4ml of dose given, vaccine started dripping from space between syringe & needle. The needle had loosen at time of removing safety cap. Pt was given 0.4mls (more than 1/2 dose) at time of injection
This spontaneous report was received from other reporter referring to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 14-JUN-2016, the patient was vaccinated with an expired dose of PNEUMOVAX23 (lot # K016589)(Not a valid Merck lot number, as verified by Merck vaccines contact. Additionally, dose, dosage number, route of administration and anatomical location were not reported). It was also stated by the reporter that PNEUMOVAX23 lot # K012424 expiration date 05-JUN-2015 was the only stock currently in the office. No concomitant medication was reported. Additional information has been requested.